Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

http://www.businessweek.com/stories/2002-05-05/table-a-rash-of-symptoms

Magazine

Table: A Rash of Symptoms


Long viewed by investors as a shelter from economic storms, the drug sector is suddenly exposed on all fronts

R&D SLOWDOWN

While the output from traditional drug discovery efforts has lagged, the payoff from new genomics-based technologies is taking longer than expected

PRICING PRESSURE

Political heat, plus pressure from managed-care companies and other big payers, will make it more difficult for drug companies to hike prices

ME-TOO COMPETITION

Copycat drugs appear on the market faster than ever, forcing drugmakers to increase marketing outlays in order to defend their big franchises

GENERIC HEADACHES

Over the next four years, drugs with a combined $30 billion in U.S. sales will lose patent protection or other forms of exclusivity, hurting revenues


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus